Literature DB >> 16684649

Phenobarbital confers its diverse effects by activating the orphan nuclear receptor car.

Susumu Kodama1, Masahiko Negishi.   

Abstract

In the early 1960s, phenobarbital (PB) was shown to induce hepatic drug metabolism and the induction was implicated in the molecular mechanism of drug tolerance development. Since then, it has become evident that PB not only induces drug metabolism, but also triggers pleiotropic effects on liver function, such as cell growth and communication, proliferation of the endoplasmic reticulum, tumor promotion, glucose metabolism, steroid/thyroid hormone metabolism, and bile acid synthesis. Upon activation by PB and numerous PB-type inducers, the nuclear receptor CAR mediates those pleiotropic actions by regulating various hepatic genes, utilizing multiple regulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684649     DOI: 10.1080/03602530600569851

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  24 in total

Review 1.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

2.  Nuclear receptor CAR-regulated expression of the FAM84A gene during the development of mouse liver tumors.

Authors:  Hiroki Kamino; Yuichi Yamazaki; Kosuke Saito; Daichi Takizawa; Satoru Kakizaki; Rick Moore; Masahiko Negishi
Journal:  Int J Oncol       Date:  2011-03-17       Impact factor: 5.650

Review 3.  Small-molecule modulators of the constitutive androstane receptor.

Authors:  Milu T Cherian; Sergio C Chai; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-05-15       Impact factor: 4.481

4.  Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanism.

Authors:  Lauren M Slosky; Brandon J Thompson; Lucy Sanchez-Covarrubias; Yifeng Zhang; Mei-Li Laracuente; Todd W Vanderah; Patrick T Ronaldson; Thomas P Davis
Journal:  Mol Pharmacol       Date:  2013-09-09       Impact factor: 4.436

Review 5.  Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities.

Authors:  Curtis J Omiecinski; John P Vanden Heuvel; Gary H Perdew; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2010-11-08       Impact factor: 4.849

6.  Energy restriction does not compensate for the reduced expression of hepatic drug-processing genes in mice with aging.

Authors:  Yu-Kun Jennifer Zhang; Kurt W Saupe; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2010-04-09       Impact factor: 3.922

7.  Cyclic AMP-dependent protein kinase signaling modulates pregnane x receptor activity in a species-specific manner.

Authors:  Kristin Lichti-Kaiser; Chenshu Xu; Jeff L Staudinger
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

8.  Nuclear xenobiotic receptor pregnane X receptor locks corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D3 activation.

Authors:  Yoshihiro Konno; Susumu Kodama; Rick Moore; Nobuhiro Kamiya; Masahiko Negishi
Journal:  Mol Pharmacol       Date:  2008-11-03       Impact factor: 4.436

Review 9.  Practical application of toxicogenomics for profiling toxicant-induced biological perturbations.

Authors:  Naoki Kiyosawa; Sunao Manabe; Takashi Yamoto; Atsushi Sanbuissho
Journal:  Int J Mol Sci       Date:  2010-09-20       Impact factor: 5.923

Review 10.  CAR and PXR: the xenobiotic-sensing receptors.

Authors:  Yoav E Timsit; Masahiko Negishi
Journal:  Steroids       Date:  2006-12-20       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.